Core Viewpoint - Cerevel Therapeutics Holdings, Inc. is facing a class action lawsuit due to allegations of misleading statements regarding its stock offering and the subsequent acquisition by AbbVie Inc. [1][2] Group 1: Allegations and Impact - The lawsuit claims that Cerevel's October 16, 2023 secondary stock offering omitted crucial information about AbbVie's interest in acquiring Cerevel at a significantly higher price than the offering price of $22.81 per share, which led to an artificially deflated stock price until the merger announcement [2] - Bain Capital, Cerevel's controlling shareholder, allegedly purchased shares during the October Offering while possessing nonpublic information about AbbVie's acquisition interest, resulting in a profit exceeding $120 million when AbbVie agreed to acquire Cerevel for $45 per share on December 6, 2023 [2] - Cerevel's January 18, 2024 Proxy statement is accused of misleading investors regarding the nature and timing of AbbVie's interest in the company [2] Group 2: Class Action Details - The class period for the lawsuit includes shareholders who sold or held shares from October 11, 2023, to August 1, 2024, and those who sold shares contemporaneously with Bain Capital's purchase on October 16, 2023 [1][2] - The deadline for shareholders to register for the class action is June 3, 2025, and there is no cost or obligation to participate [3] - Registered shareholders will receive updates through a portfolio monitoring software throughout the case lifecycle [3] Group 3: Legal Representation - The Gross Law Firm, a nationally recognized class action law firm, is representing the shareholders and aims to protect investors from deceit and illegal business practices [4] - The firm emphasizes the importance of responsible business practices and seeks recovery for investors affected by misleading statements or omissions that led to stock price inflation [4]

Core Viewpoint - Fluence Energy, Inc. is facing allegations of issuing materially false and misleading statements regarding its business relationships and financial performance during the class period from October 28, 2021, to February 10, 2025 [1] Group 1: Allegations - The complaint alleges that Fluence's relationship with its founders and major revenue sources, Siemens AG and The AES Corporation, was expected to decline [1] - Siemens Energy, a U.S. affiliate of Siemens AG, accused Fluence of engineering failures and fraud [1] - Fluence's reported margins and revenue growth were allegedly inflated as Siemens and AES were moving towards divestment [1] - Due to these issues, the defendants lacked a reasonable basis for their positive statements regarding Fluence's battery energy storage business and its financial results, growth, and prospects [1] Group 2: Class Action Details - Shareholders who purchased FLNC shares during the specified class period are encouraged to register for the class action, with a deadline of May 12, 2025 [2] - Registered shareholders will be enrolled in a portfolio monitoring software to receive updates throughout the case lifecycle [2] - There is no cost or obligation for shareholders to participate in this case [2]

Core Viewpoint - Solaris Energy Infrastructure, Inc. (NYSE: SEI) is facing a class action lawsuit due to allegations of issuing materially false and misleading statements regarding its business operations and the acquisition of Mobile Energy Rentals LLC (MER) [1][3]. Allegations - The complaint alleges that during the class period from July 9, 2024, to March 17, 2025, the defendants failed to disclose critical information about MER, including its lack of corporate history in mobile turbine leasing and a non-diversified earnings stream [3]. - It is claimed that MER's co-owner has a criminal background associated with turbine-related fraud, which was not disclosed, leading to an overstatement of the commercial prospects of the acquisition [3]. - The lawsuit also alleges that Solaris inflated its profitability metrics by not properly depreciating its turbines, resulting in misleading positive statements about the company's business and operations [3]. Class Action Details - Shareholders who purchased SEI shares during the specified class period are encouraged to register for the class action, with a deadline set for May 27, 2025 [4]. - Participants will be enrolled in a portfolio monitoring system to receive updates on the case's progress [4]. Law Firm Information - The Gross Law Firm, a nationally recognized class action law firm, is representing the shareholders and aims to protect investors' rights against deceit and fraud [5].

NEW YORK, May 01, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Everus Construction Group, Inc. (NYSE: ECG). Shareholders who purchased shares of ECG during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/everus-construction-group-inc-loss-submission-form/?id=146190&from=3 CL ...

NEW YORK, May 01, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Ibotta, Inc. (NYSE: IBTA). Shareholders who purchased shares of IBTA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/ibotta-loss-submission-form/?id=146181&from=3 CLASS PERIOD: This lawsuit is on behalf of ...

Core Viewpoint - The article discusses a class action lawsuit against Cerevel Therapeutics Holdings, Inc. related to alleged misleading statements and omissions regarding AbbVie's acquisition interest, which impacted the stock price during a secondary offering [1][2]. Group 1: Allegations and Impact - Cerevel's October 16, 2023 secondary stock offering documents allegedly omitted material facts about AbbVie's interest in acquiring Cerevel at a significantly higher price than the offering price of $22.81 per share, leading to an artificially deflated stock price until the merger announcement [2]. - Bain Capital, Cerevel's controlling shareholder, reportedly acquired shares at the depressed price while possessing nonpublic information about AbbVie's acquisition interest, resulting in a windfall of over $120 million when AbbVie agreed to acquire Cerevel for $45 per share on December 6, 2023 [2]. - The January 18, 2024 Proxy statement from Cerevel allegedly misled investors regarding the nature and timing of AbbVie's interest in the company [2]. Group 2: Class Action Details - The class period for the lawsuit includes individuals who sold or disposed of Cerevel stock from October 11, 2023, to August 1, 2024, and those who held shares as of January 8, 2024, entitled to vote on the merger [1]. - The deadline for shareholders to register for the class action is June 3, 2025, and there is no cost or obligation to participate [3]. - Registered shareholders will receive updates through a portfolio monitoring software throughout the case lifecycle [3]. Group 3: Law Firm Information - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit and fraud, ensuring companies adhere to responsible business practices [4].

NEW YORK, May 1, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Everus Construction Group, Inc. (NYSE: ECG).Shareholders who purchased shares of ECG during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/everus-construction-group-inc-loss-submission-form/?id=146169&from=4CLASS PERIO ...

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of BigBear.ai Holdings, Inc. regarding a class action lawsuit due to alleged misleading statements and accounting errors during the class period from March 31, 2022, to March 25, 2025 [1][2]. Summary by Sections Allegations - The complaint alleges that BigBear maintained deficient accounting review policies related to the reporting and disclosure of certain non-routine, unusual, or complex transactions [2] - It is claimed that BigBear incorrectly determined that the conversion option within the 2026 Convertible Notes qualified for the derivative scope exception under ASC 815-40 and failed to bifurcate the conversion option as required by ASC 815-15 [2] - The company is accused of improperly accounting for the 2026 Convertible Notes, leading to misstatements in several previously issued financial statements [2] - As a result of these errors, the financial statements were deemed inaccurate and likely to require restatement, increasing the risk of delays in filing financial reports with the SEC [2] Next Steps for Shareholders - Shareholders are encouraged to register for the class action by June 10, 2025, to monitor the case's progress [3] - Registration will provide shareholders with status updates throughout the lifecycle of the case, with no cost or obligation to participate [3] About the Law Firm - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors affected by deceit, fraud, and illegal business practices [4] - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements or omissions [4]

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Skyworks Solutions, Inc. regarding a class action lawsuit due to alleged misleading statements about the company's expected revenue for fiscal year 2025, which led to a significant drop in stock price following disappointing financial results [1]. Group 1: Allegations and Financial Impact - The allegations state that defendants provided investors with material information about Skyworks' expected revenue, expressing confidence in the company's ability to grow its mobile business and diversify its offerings through new technologies [1]. - On February 5, 2025, Skyworks announced its first-quarter financial results for fiscal year 2025, revealing lower-than-expected revenue guidance for the second quarter, attributing this to an intensified competitive landscape [1]. - Following the announcement, Skyworks' stock price plummeted from $87.08 per share on February 5, 2025, to $65.60 per share on February 6, 2025, marking a decline of over 24% in just one day [1]. Group 2: Class Action Details - Shareholders who purchased shares of SWKS during the class period from August 8, 2023, to February 5, 2025, are encouraged to register for the class action, with a deadline of May 5, 2025, to seek lead plaintiff status [2]. - Once registered, shareholders will be enrolled in a portfolio monitoring software to receive updates throughout the case lifecycle, with no cost or obligation to participate [2]. Group 3: Law Firm's Mission - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors who have suffered due to deceit, fraud, and illegal business practices [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who incurred losses from misleading statements or omissions that artificially inflated stock prices [3].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Cerevel Therapeutics Holdings, Inc. regarding a class action lawsuit related to alleged misleading statements and omissions during a secondary stock offering, which may have impacted the stock price prior to a merger announcement with AbbVie Inc. [1][4] Group 1: Class Action Details - The class period for the lawsuit is from October 11, 2023, to August 1, 2024, and includes shareholders who sold or held shares during this timeframe [3]. - Shareholders are encouraged to register for the class action, with a deadline for lead plaintiff appointment set for June 3, 2025 [5]. Group 2: Allegations Against Cerevel - The complaint alleges that Cerevel's October 16, 2023 secondary stock offering omitted material facts about AbbVie's interest in acquiring Cerevel at a significantly higher price than the offering price of $22.81 per share [4]. - Bain Capital, Cerevel's controlling shareholder, allegedly acquired shares at an artificially depressed price while possessing nonpublic information about AbbVie's acquisition interest, resulting in a windfall of over $120 million when AbbVie agreed to acquire Cerevel for $45 per share [4]. Group 3: Next Steps for Shareholders - Shareholders who register will be enrolled in a portfolio monitoring system to receive updates on the case [5]. - Participation in the class action has no cost or obligation for shareholders [5].